Syngene International expands ongoing research collaboration with Amgen

28 Jul 2017 Evaluate

Syngene International has expanded its ongoing research collaboration with Amgen Inc. As a result, Syngene will expand the Syngene Amgen Research & Development Center (SARC) in terms of size and scope of its operations. The expansion of SARC will be customized to meet Amgen’s functional requirements and will include a range of environment-friendly features that will enable optimal utilization of the laboratory space.

With the expansion, the floor space of SARC will double to 50,000 square feet. A team of up to 185 multi-disciplinary Syngene scientists will work at SARC in the areas of medicinal and process chemistry, biologics, bioprocess development, drug metabolism, pharmacokinetics, bioanalytical research and pharmaceutical development.

Syngene International is India’s largest Contract Research Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.


Syngene Internation. Share Price

683.25 9.10 (1.35%)
18-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 683.25
Sagility India 42.29
AGS Transact Tech 11.46
Just Dial 837.00
Krystal Integrated 428.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...